Centene Offers Higher-Than-Expected EPS Guidance for 2025

  • Dec 13, 2024

    During its Investor Day on Dec. 12, Centene Corp. projected it would have adjusted earnings per share (EPS) next year of at least $7.25, above the Wall Street consensus of $7.05. Wells Fargo analyst Stephen Baxter wrote in a Dec. 12 note that “barring any surprises,” the guidance was “a positive” and “modestly favorable.”  

    The adjusted EPS guidance represents a 6.6% increase over this year’s projection of at least $6.80 and comes amid a Medicaid market that Centene CEO Sarah London noted “has experienced a period of intense disruption over the last 18 months” due to the redetermination process that began in April 2023. Since then, millions of Medicaid beneficiaries have lost coverage, while the remaining Medicaid members have, on average, been sicker and used more services even as reimbursement rates to insurers have not always increased in line with the higher costs. 

    Read more
    © 2024 MMIT
  • Tim Casey

    Tim has been a reporter and editor for newspapers, websites and magazines for more than 20 years, including 10 years covering health care business topics. He has a deep knowledge of the managed care industry and pharmacy benefit management. He also has experience covering medical conferences and clinical and legislative health care issues. In 2014, the Society for Advancing Business Editing and Writing selected Tim as one of 15 journalists to participate in a national symposium on the Affordable Care Act. Tim has a B.A. in Psychology from the University of Notre Dame and an M.B.A. from Georgetown University.

The Latest
Meet Our Reporters

Meet Our Reporters

×